特朗普和AstraZeneca的交易 控制毒品价格 推广非专利药 于2026年生效 Trump's deal with AstraZeneca to cap drug prices and boost generics takes effect in 2026.

总统特朗普宣布与制药公司AstraZeneca达成新协议, 旨在降低美国消费者的药品价格。 President Trump announced a new agreement with pharmaceutical company AstraZeneca aimed at lowering drug prices for American consumers. 这项交易定于2026年生效,包括承诺限制主要药品的价格上涨,扩大获得低成本非专利药物的机会。 The deal, set to take effect in 2026, includes commitments to cap price increases on key medications and expand access to lower-cost generics. 行政当局称该协议是朝着降低处方费用迈出的重要一步,尽管关于受影响药物和执行机制的细节仍然有限。 The administration cited the agreement as a major step toward reducing prescription costs, though specifics on affected drugs and enforcement mechanisms remain limited.